- Home
- MPV vs ALEC Comparison
MPV vs ALEC Comparison
Compare MPV & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPV | ALEC |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 167.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MPV | ALEC |
|---|---|---|
| Price | $16.92 | $2.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 22.1K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $29.87 |
| P/E Ratio | $9.95 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.05 | $1.09 |
| 52 Week High | $20.58 | $3.40 |
Technical Indicators
Market Signals| Indicator | MPV | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 61.51 | 56.17 |
| Support Level | $15.88 | $1.93 |
| Resistance Level | $17.57 | $2.62 |
| Average True Range (ATR) | 0.46 | 0.20 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 89.47 | 37.19 |
Price Performance
Historical ComparisonAbout MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.